Abstract:
A flexible heat-sealable web is shaped continuously into a tubular cross-sectional shape, e.g. as an intermediate stage in the production of infusion bags comprising severed and sealed lengths of the tubular shape. The web is drawn along a shaped shoe and side margins of the web are folded over opposite sides of the shoe by rollers and fingers to place the opposite side edges of the web in overlapping relationship against the shoe. The overlapped edges pass between a roller mounted in the shoe and an external heated roller to be pressed between the two rollers in order to lap weld the edges together as the web travels along the shoe. The shoe continues to form the web downstream of the welding station into a flattened tube.
Abstract:
The invention relates to the generation of non-human transgenic animals comprising a reporter construct for producing a detectable amount of a reporter molecule operably linked to a transcriptional regulatory nucleic acid molecule from the human CYP3A4 gene located between the initiation of transcription site of the gene and a position located 13,000 nucleotides upstream from the site. The invention also relates to the use of these animals for determining the effect of a compound, particularly, but not exclusively, a xenobiotic or steroid, on the regulation of expression of the CYP3A4 gene in a human.
Abstract:
This disclosure provides novel ways to modify/functionalize, including crosslink, ligands in the surface coating or molecules in other coatings on a nanoparticle, by using radical addition reactions to add a reactant group onto a ligand/molecule of a nanoparticle. Examples include using a functionalized benzophenone that can be attached or crosslinked to a ligand in the surface coating of a nanocrystal by photochemically-initiated radical addition.
Abstract:
An isolated nucleic acid molecule comprising a nucleotide sequence encoding a transcriptional enhancer of cytochrome P450 (P450) CYP3A4 production or expression, and uses of the nucleic acid molecule for screening compounds for xenobiotic induction of CYP3A4 expression in cells and animals.
Abstract:
A system is described having a network, a bus and an interface coupling the network to the bus. A host is coupled to the network and executes software to generate packets for communication on the network. A bus device is coupled to the bus. The interface and host coordinate to transport bus device packets between the host and the bus device via tunneling over the network.
Abstract:
A method for forming a coating on a substrate using an atmospheric pressure plasma discharge. The method comprises introducing an atomized liquid and/or solid coating-forming material into an atmospheric pressure plasma discharge and/or an ionized gas stream resulting therefrom, and exposing the substrate to the atomized coating-forming material. The application also described a method for polymerizing a polymer forming material, and further to apparatus for forming a coating on a substrate.
Abstract:
Methods or prevention or treatment of diseases or conditions caused by low plasma apoA-1 levels, the use of LRH1 activators in such methods and methods for identification of compounds useful in such treatment.
Abstract:
A system is described having a network, a bus and an interface coupling the network to the bus. A host is coupled to the network and executes software to generate packets for communication on the network. A bus device is coupled to the bus. The interface and host coordinate to transport bus device packets between the host and the bus device via tunneling over the network.
Abstract:
The present invention relates to methods for making an alcoholic beverage. In particular, the invention relates to methods for making an alcoholic beverage comprising distilling a first portion of an alcoholic mixture to provide a first distillate; distilling a second portion of the alcoholic mixture under conditions sufficient to provide a second distillate having a composition different from the first distillate; and admixing at least a portion of the first distillate and at least a portion of the second distillate to make a first blend. The first blend may optionally be aged, proof-adjusted, sparged with gas, and/or filtered to provide an alcoholic beverage. In one embodiment, the alcoholic beverage is tequila.
Abstract:
An isolated nucleic acid molecule comprising a nucleotide sequence encoding a transcriptional enhancer of cytochrome P450 (P450) CYP3A4 production or expression is disclosed, as are uses of the nucleic acid molecule for screening compounds for xenobiotic induction of CYP3A4 expression in cells and animals.